Aurion Biotech, Inc.
Records under this name other than the patents Aurion Biotech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 5 of 5 · Back to Aurion Biotech, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,072,334 | Corneal Endothelial Cell Marker Formerly held In force · High confidence | In force | High confidence | |
| US 10,004,707 | Method for Treating Cancer with Low Molecular Weight Components of Aurin Tricarboxylic Acid Complex Lapsed on the fee record Ended Jun 26, 2026 · High confidence | Lapsed on the fee record | Ended Jun 26, 2026 | High confidence |
| US 11,013,750 | Methods for treating and preventing nociceptive pain Lapsed on the fee record Ended May 25, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 25, 2025 | From the USPTO record |
| US 10,966,945 | Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic synthetic complex Lapsed on the fee record Ended Apr 6, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 6, 2025 | From the USPTO record |
| US 10,398,666 | Method for Treating Cancer with Low Molecular Weight Components of Aurin Tricarboxylic Acid Complex Lapsed on the fee record Ended Sep 3, 2023 · High confidence | Lapsed on the fee record | Ended Sep 3, 2023 | High confidence |